Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tim Leest"'
Autor:
Segundo Mariz, Fernando Mendez-Hermida, Violeta Stoyanova-Beninska, Maria E. Sheean, Laura Fregonese, Dinko Vitezić, Armando Magrelli, Nikolaos V. Sipsas, Tim Leest, Stelios Tsigkos, Dinah Duarte, Bruno Sepodes, Eva Malikova, Robert Nistico, Giuseppe Capovilla, Matthias P. Hofer, Kristina Larsson
Publikováno v:
Drug Discovery Today
Volume 25
Issue 2
Volume 25
Issue 2
The Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) is responsible for evaluating applications for orphan designation (OMPDs) and for deciding the orphan status at the time of marketing authorization of medicines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e58e9b1e4b49f0c050ffbef7f5ce2103
http://hdl.handle.net/2108/227456
http://hdl.handle.net/2108/227456
Autor:
Jordi Llinares Garcia, Anne Miermont, Tim Leest, Kyriaki Tzogani, Sahra Ali, Francesco Pignatti, Koenraad Norga, Jan Mueller-Berghaus, Tomas Salmonson, Martina Schuessler-Lenz, Benjamin Hofner, Irene Papadouli, Olga Kholmanskikh, Frank Pétavy, Christian Gisselbrecht, Claire Beuneu
Publikováno v:
Oncologist
The oncologist
The oncologist
On June 28, 2018, the Committee for Advanced Therapies and the Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Yescarta for the treatment of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::365c9c5e6d36bbac8d2424db7087c8f3
https://pubmed.ncbi.nlm.nih.gov/32339368
https://pubmed.ncbi.nlm.nih.gov/32339368
